Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation

Endothelial and Complement Activation As Predictors of Survival in Adult Allogeneic Hematopoietic Cell Transplantation

Bibliographic Details
Main Authors:	Eleni Gavriilaki, Ioanna Sakellari, Thomas Chatzikonstantinou, Despina Mallouri, Ioannis Batsis, Anna Vardi, Zoi Bousiou, Eudoxia-Evaggelia Koravou, Marianna Masmanidou, Tasoula Touloumenidou, Apostolia Papalexandri, Anastasia Athanasiadou, Evangelia Yannaki, Achilles Anagnostopoulos
Format:	Article
Language:	English
Published:	Wiley 2021-01-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/HS9.0000000000000487

Similar Items

Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients
by: Eleni Gavriilaki, et al.
Published: (2023-12-01)

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
by: Apostolia Papalexandri, et al.
Published: (2023-11-01)

Allogeneic Hematopoietic Cell Transplantation in Patients With Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria Clones: Time for a Change
by: Eleni Gavriilaki, et al.
Published: (2020-04-01)

Pre- and Post-transfusion Complement Activation in Transfusion-dependent β-thalassaemia
by: Eleni Gavriilaki, et al.
Published: (2018-10-01)

PB2183: RELAPSE PREDICTS POOR OUTCOMES IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA POST ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
by: E. Gavriilaki, et al.
Published: (2022-06-01)

Patient risk stratification and tailored clinical management of post‐transplant CMV‐, EBV‐, and BKV‐infections by monitoring virus‐specific T‐cell immunity
by: Anastasia Papadopoulou, et al.
Published: (2021-08-01)

Immune Response of Adult Sickle Cell Disease Patients after COVID-19 Vaccination: The Experience of a Greek Center
by: Christos Varelas, et al.
Published: (2022-02-01)

Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation
by: Eleni Gavriilaki, et al.
Published: (2020-12-01)

P1311: LONG-TERM SAFETY AND EFFICACY OF EXTRACORPOREAL PHOTOPHERESIS AS EARLY SECOND-LINE TREATMENT FOR PATIENTS WITH STEROID-DEPENDENT OR REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE.
by: Eleni Gavriilaki, et al.
Published: (2023-08-01)

Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis
by: Eleni Gavriilaki, et al.
Published: (2023-07-01)

P1395: PENTAVALENT-SPECIFIC T-CELLS POST HAPLO-IDENTICAL TRANSPLANTATION FOR THE TREATMENT OF OPPORTUNISTIC INFECTIONS
by: Zoi Bousiou, et al.
Published: (2023-08-01)

PB2261: DECREASE IN NEUTROPHIL-LYMPHOCYTE RATIO IMPACTS OVERALL SURVIVAL OF ADULT PATIENTS WITH HODGKIN LYMPHOMA AFTER ANTI-PD1 TREATMENT
by: Christos Varelas, et al.
Published: (2023-08-01)

Blast Crisis of CML After TKI Discontinuation in a Patient With Previous Stable Deep Molecular Response: Is It Safe to Stop?
by: Apostolia Papalexandri, et al.
Published: (2018-12-01)

A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity
by: Eleni Gavriilaki, et al.
Published: (2020-05-01)

Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor
by: Dionysios Vythoulkas, et al.
Published: (2023-04-01)

Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection
by: Eleni Gavriilaki, et al.
Published: (2022-06-01)

PB1894: NPM1 MUTATED ACUTE MYELOID LEUKEMIA: THE CO-MUTATION PATTERNS MAY BE ASSOCIATED WITH PROGNOSIS
by: Christos Varelas, et al.
Published: (2023-08-01)

Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World Experience
by: E. Gavriilaki, et al.
Published: (2023-08-01)

Real-world data of thrombotic microangiopathy management: The key role of ADAMTS13 activity and complement testing
by: Eleni Gavriilaki, et al.
Published: (2021-05-01)

Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls
by: Eleni Gavriilaki, et al.
Published: (2022-06-01)

PB2226: THE ROLE OF COMPLEMENT IN THE IMMUNE RESPONSE OF SICKLE CELL DISEASE PATIENTS AFER COVID-19 VACCINATION
by: C. Varelas, et al.
Published: (2022-06-01)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
by: Christos Demosthenous, et al.
Published: (2021-05-01)

Robust SARS-COV-2-specific T-cell immune memory persists long-term in immunocompetent individuals post BNT162b2 double shot
by: Anastasia Papadopoulou, et al.
Published: (2022-07-01)

Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data
by: Eleni Gavriilaki, et al.
Published: (2023-10-01)

P1698: INCREASED COMPLEMENT ACTIVATION AND DECREASED ADAMTS13 ACTIVITY IN PATIENTS WITH PRE-ECLAMPSIA COMPARED TO HEALTHY PREGNANCIES
by: T. M. Venou, et al.
Published: (2022-06-01)

Promises and Pitfalls of Next-Generation Treg Adoptive Immunotherapy
by: Panayiota Christofi, et al.
Published: (2023-12-01)

Economic Education in Greece at the High School Level
by: Despina Bousiou, et al.
Published: (2003-02-01)

Development of a Method for the In Vivo Generation of Allogeneic Hearts in Chimeric Mouse Embryos
by: Konstantina-Maria Founta, et al.
Published: (2023-01-01)

Molecular Advances in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease
by: Ioulia Mavrikou, et al.
Published: (2023-03-01)

Current status and developments in gene therapy for thalassemia and sickle cell disease
by: Evangelia Yannaki, et al.
Published: (2014-12-01)

Graft-Versus-Host Disease: Can Biomarkers Assist in Differential Diagnosis, Prognosis, and Therapeutic Strategy?
by: Vaia-Aikaterini Alexoudi, et al.
Published: (2024-02-01)

Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies
by: Kiriaki Paschoudi, et al.
Published: (2023-05-01)

Reinforcing the Immunocompromised Host Defense against Fungi: Progress beyond the Current State of the Art
by: Georgios Karavalakis, et al.
Published: (2021-06-01)

Housing, energy performance and social challenges in Greece. A quantitative approach
by: Chatzikonstantinou Evangelia, et al.
Published: (2023-01-01)

Transplant-Associated Thrombotic Microangiopathy in the Context of Allogenic Hematopoietic Stem Cell Transplantation: Where We Stand
by: Ioanna Lazana
Published: (2023-01-01)

Endothelial Dysfunction Syndromes after Allogeneic Stem Cell Transplantation
by: Dionysios Vythoulkas, et al.
Published: (2023-01-01)

Nature of Science in Greek Secondary School Biology Textbooks
by: Nausica Kapsala, et al.
Published: (2022-06-01)

In Vivo Hematopoietic Stem Cell Genome Editing: Perspectives and Limitations
by: Nikoletta Psatha, et al.
Published: (2022-11-01)

On P-H_v-Structures in a Two-Dimensional Real Vector Space
by: Ioanna Iliou, et al.
Published: (2017-12-01)

A Novel, Cell-Free Therapy to Enter Our Hearts: The Potential Role of Small EVs in Prevention and Treatment of CVD
by: Ioanna Lazana, et al.
Published: (2022-03-01)